Margarete S Mendonça Gomes
Research Subjects
Research Interests
Margarete S Mendonça Gomes has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Abdelkrim Smine
20Consultant to the Promoting the Quality of Medicines Program, Casablanca, Morocco
1 shared publication - Adrian Barojas
Promoting the Quality of Medicines Program, United States Pharmacopeia, Rockville, MD, 20852, USA
1 shared publication - Alison Hinds-Semple
Food and Drug Department, Ministry of Health, Georgetown, Guyana
1 shared publication - Arletta Añez
Departamento de Salud Pública, Universidad de Barcelona, Barcelona, Spain
1 shared publication - Cecilia G López
Laboratorio de Control de Calidad de Medicamentos y Toxicología, Instituto Nacional de Laboratorios de Salud, La Paz, Bolivia
1 shared publication - Fernando Henrique Andrade Nogueira
Department of Pharmacy, Center of Health Sciences, Federal University of Rio Grande do Norte, Natal 59012-570, Brazil
1 shared publication
Latest Publications
- Open Access
- 15 June 2012
- Published by Springer Nature in Malaria Journal
- Vol. 11 (1) , 202
Implementation of basic quality control tests for malaria medicines in Amazon Basin countries: results for the 2005–2010 period
Ensuring the quality of malaria medicines is crucial in working toward malaria control and eventual elimination. Unlike other validated tests that can assess all critical quality attributes, which is the standard for determining the quality of medicines, basic tests are significantly less expensive, faster, and require less skilled labour; yet, these tests provide reproducible data and information on several critical quality attributes, such as identity, purity, content, and disintegration. Visual and physical inspection also provides valuable information about the manufacturing and the labelling of medicines, and in many cases this inspection is sufficient to detect counterfeit medicines. The Promoting the Quality of Medicines (PQM) programme has provided technical assistance to Amazon Malaria Initiative (AMI) countries to implement the use of basic tests as a key screening mechanism to assess the quality of malaria medicines available to patients in decentralized regions.
- 15 June 2012
- Published by Springer Nature in Malaria Journal
- Vol. 11 (1) , 202
Open AccessImplementation of basic quality control tests for malaria medicines in Amazon Basin countries: results for the 2005–2010 period
Ensuring the quality of malaria medicines is crucial in working toward malaria control and eventual elimination. Unlike other validated tests that can assess all critical quality attributes, which is the standard for determining the quality of medicines, basic tests are significantly less expensive, faster, and require less skilled labour; yet, these tests provide reproducible data and information on several critical quality attributes, such as identity, purity, content, and disintegration. Visual and physical inspection also provides valuable information about the manufacturing and the labelling of medicines, and in many cases this inspection is sufficient to detect counterfeit medicines. The Promoting the Quality of Medicines (PQM) programme has provided technical assistance to Amazon Malaria Initiative (AMI) countries to implement the use of basic tests as a key screening mechanism to assess the quality of malaria medicines available to patients in decentralized regions.